RECRUITING

Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement

Description

The goal of this project is to measure the clinical utility of an objective and quantitative eye-tracking assay collected on a standalone, mobile investigational device to accurately screen 9-month-old infants for autism spectrum disorder and other actionable delays.

Study Overview

Study Details

Study overview

The goal of this project is to measure the clinical utility of an objective and quantitative eye-tracking assay collected on a standalone, mobile investigational device to accurately screen 9-month-old infants for autism spectrum disorder and other actionable delays.

Community-viable Screening for Autism Spectrum Disorder (ASD) in 9-month-old Infants Using Quantitative Eye-tracking Assays of Social Visual Engagement

Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement

Condition
Autism
Intervention / Treatment

-

Contacts and Locations

Atlanta

Children's Healthcare of Altanta, Atlanta, Georgia, United States, 30322

Atlanta

Emory Univeristy, Atlanta, Georgia, United States, 30329

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Infants between the chronological ages of 8-10 months;
  • * Infants must be generally healthy with no acute illnesses likely to prevent successful or valid data collection (e.g., current vomiting, high fever, conjunctivitis affecting vision);
  • * participants' parents/caregivers must be able to understand and voluntarily provide written informed consent.

Ages Eligible for Study

8 Months to 10 Months

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Emory University,

Warren R Jones, PhD, PRINCIPAL_INVESTIGATOR, Emory University

Study Record Dates

2027-12